237 related articles for article (PubMed ID: 9216681)
1. Cytokinetic and morphologic differences in ovarian cancer cells treated with ET-18-OCH3 and the DNA-interacting agent, etoposide.
Fujiwara K; Koike H; Ohishi Y; Shirafuji H; Kohno I; Modest EJ; Kataoka S
Anticancer Res; 1997; 17(3C):2159-67. PubMed ID: 9216681
[TBL] [Abstract][Full Text] [Related]
2. Cell kill and cytostasis by ET-18-OCH3 and heat.
Fujiwara K; Modest EJ; Wallen CA
Anticancer Res; 1995; 15(4):1333-8. PubMed ID: 7654017
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic interactions of heat and an ether lipid analogue in human ovarian carcinoma cells.
Fujiwara K; Modest EJ; Welander CE; Wallen CA
Cancer Res; 1989 Nov; 49(22):6285-9. PubMed ID: 2804975
[TBL] [Abstract][Full Text] [Related]
4. Change in the localization of heat shock protein 27 (HSP 27) in BG-1 human ovarian cancer cells following treatment by the ether lipid ET-18-OCH3.
Fujiwara K; Shirafuji H; Fushitani K; Fujimoto K; Kohno I; Modest EJ
Anticancer Res; 1999; 19(1A):181-7. PubMed ID: 10226541
[TBL] [Abstract][Full Text] [Related]
5. Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells.
Kataoka S; Naito M; Tomida A; Tsuruo T
Exp Cell Res; 1994 Nov; 215(1):199-205. PubMed ID: 7957669
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of CDDP cytotoxicity by caffeine is characterized by apoptotic cell death.
Shinomiya N; Shinomiya M; Wakiyama H; Katsura Y; Rokutanda M
Exp Cell Res; 1994 Feb; 210(2):236-42. PubMed ID: 8299722
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effect of GnRH agonist in epithelial ovarian cancer.
Kim JH; Park DC; Kim JW; Choi YK; Lew YO; Kim DH; Jung JK; Lim YA; Namkoong SE
Gynecol Oncol; 1999 Aug; 74(2):170-80. PubMed ID: 10419728
[TBL] [Abstract][Full Text] [Related]
8. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341.
Frankel A; Man S; Elliott P; Adams J; Kerbel RS
Clin Cancer Res; 2000 Sep; 6(9):3719-28. PubMed ID: 10999766
[TBL] [Abstract][Full Text] [Related]
9. [Cancer chemo-endocrine therapy and its cell biological basis].
Nishiya I
Hum Cell; 1998 Sep; 11(3):109-14. PubMed ID: 10086273
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell kinetics following long-term treatment with antineoplastic ether phospholipids.
Principe P; Sidoti C; Coulomb H; Broquet C; Braquet P
Cancer Detect Prev; 1994; 18(5):393-400. PubMed ID: 7812986
[TBL] [Abstract][Full Text] [Related]
11. Activation of actin-cleavable interleukin 1beta-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells.
Chen Z; Naito M; Mashima T; Tsuruo T
Cancer Res; 1996 Nov; 56(22):5224-9. PubMed ID: 8912861
[TBL] [Abstract][Full Text] [Related]
12. Further characterisation of the in situ terminal deoxynucleotidyl transferase (TdT) assay for the flow cytometric analysis of apoptosis in drug resistant and drug sensitive leukaemic cells.
Chapman RS; Chresta CM; Herberg AA; Beere HM; Heer S; Whetton AD; Hickman JA; Dive C
Cytometry; 1995 Jul; 20(3):245-56. PubMed ID: 7587710
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy of paclitaxel and cisplatin induces apoptosis with Bcl-2 phosphorylation in a cisplatin-resistant human epidermoid carcinoma cell line.
Sawada S; Mese H; Sasaki A; Yoshioka N; Matsumura T
Cancer Chemother Pharmacol; 2003 Jun; 51(6):505-11. PubMed ID: 12709826
[TBL] [Abstract][Full Text] [Related]
14. Tumor cell kinetics following antineoplastic ether phospholipid treatment.
Principe P; Sidoti C; Braquet P
Cancer Res; 1992 May; 52(9):2509-15. PubMed ID: 1568220
[TBL] [Abstract][Full Text] [Related]
15. E1A overcomes the apoptosis block in BCR-ABL+ leukemia cells and renders cells susceptible to induction of apoptosis by chemotherapeutic agents.
Stiewe T; Parssanedjad K; Esche H; Opalka B; Pützer BM
Cancer Res; 2000 Jul; 60(14):3957-64. PubMed ID: 10919674
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.
Judson PL; Watson JM; Gehrig PA; Fowler WC; Haskill JS
Cancer Res; 1999 May; 59(10):2425-32. PubMed ID: 10344753
[TBL] [Abstract][Full Text] [Related]
17. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Chabot MC; Wykle RL; Modest EJ; Daniel LW
Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
[TBL] [Abstract][Full Text] [Related]
18. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
O'Neill CF; Koberle B; Masters JR; Kelland LR
Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies.
Caserini C; Pratesi G; Tortoreto M; Bedogné B; Carenini N; Supino R; Perego P; Righetti SC; Zunino F
Clin Cancer Res; 1997 Jun; 3(6):955-61. PubMed ID: 9815771
[TBL] [Abstract][Full Text] [Related]
20. [The relationship between morphological manifestations and cell kinetic changes of human lung cancer cells after exposure to chemotherapeutic agents].
Ito M
Hokkaido Igaku Zasshi; 1986 Sep; 61(5):718-36. PubMed ID: 2430876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]